|
2024
|
Invention
|
Systems and compositions comprising highly active trans-amplifying replicases. Described herein a... |
|
2023
|
Invention
|
Antibodies specific for claudin 6 (cldn6).
The present invention provides antibodies useful as t... |
|
|
Invention
|
Systems and compositions comprising trans-amplifying rna vectors with mirna. The present inventio... |
|
|
Invention
|
Methods and compositions for localized expression of administered rna. Disclosed herein are metho... |
|
|
Invention
|
Agents and methods for targeted delivery of cytokines to immune cells. The invention relates to a... |
|
2022
|
G/S
|
Science and technology services, Especially, Relating to the following sectors, Innovative diagno... |
|
|
G/S
|
Personal development by means of training and further training for doctors and scientists in the ... |
|
|
Invention
|
Methods for determining mutations for increasing modified replicable rna function and related com... |
|
|
Invention
|
Modified replicable rna and related compositions and their use. The present invention relates to ... |
|
|
Invention
|
Treatment involving non-immunogenic rna for antigen vaccination and pd-1 axis binding antagonists... |
|
|
Invention
|
Methods and compositions for diagnosis and treatment of cancer.
The present invention relates to... |
|
|
G/S
|
Scientific and technological services, in the nature of scientific research, in relation to the f... |
|
|
G/S
|
Scientific and technological services, especially, in
relation to the following fields, innovati... |
|
|
G/S
|
Scientific and technological services, especially, in relation to the following fields, innovativ... |
|
|
Invention
|
Replicon compositions and methods of using same for the treatment of diseases. The present invent... |
|
2021
|
Invention
|
Therapeutic rna for lung cancer. This disclosure relates to the field of RNA to treat lung cancer... |
|
|
Invention
|
Therapeutic rna for hpv-positive cancer. This disclosure relates to the field of therapeutic RNA ... |
|
|
Invention
|
Rna replicon for versatile and efficient gene expression. The present invention embraces an RNA r... |
|
|
G/S
|
Science and technology services, Especially, in relation to the following fields, Innovative diag... |
|
|
Invention
|
Treatment involving non-immunogenic rna for antigen vaccination. The present disclosure relates t... |
|
|
G/S
|
Science and technology services, In particular in the field of innovative diagnosis and therapy o... |
|
|
G/S
|
Software for medical and biotechnological applications, in
particular in the fields of diagnosti... |
|
2020
|
Invention
|
Antibodies for treatment of cancer expressing claudin 6. The present invention provides antibodie... |
|
|
Invention
|
Antibodies specific for claudin 6 (cldn6). The present invention provides antibodies useful as th... |
|
|
Invention
|
Therapeutic rna for ovarian cancer. Disclosed herein are compositions, uses, and methods for trea... |
|
|
Invention
|
Therapeutic rna for prostate cancer. Disclosed herein are compositions, uses, and methods for tre... |
|
|
Invention
|
Localized administration of rna molecules for therapy. The present invention relates to local del... |
|
2019
|
G/S
|
Research in the field of medicine and biotechnology, in particular in the field of cancer researc... |
|
|
G/S
|
Financial sponsorship of scientists; Financial sponsorship of science and research, in particular... |
|
|
Invention
|
Treatment involving therapeutic antibody and interleukin-2 (il2). Tumor cells often evade an immu... |
|
|
G/S
|
Science and technology services; Research and development; Chemical and molecular biology laborat... |
|
|
G/S
|
Software, in particular software for the prediction of fusion genes. |
|
|
Invention
|
Il2 agonists. The invention relates to variants of interleukin-2 (IL2). In one embodiment, the IL... |
|
|
Invention
|
Treatment involving interleukin-2 (il2) and interferon (ifn). The present disclosure relates to m... |
|
|
Invention
|
Methods and compositions for diagnosis and treatment of cancer. The present invention relates to ... |
|
|
Invention
|
Treatment using cytokine encoding rna. The present disclosure relates to methods and compositions... |
|
2018
|
Invention
|
Therapy involving antibodies against claudin 18.2 for treatment of cancer. 2. Furthermore, data a... |
|
|
Invention
|
Rna replicon for expressing a t cell receptor or an artificial t cell receptor. The present inven... |
|
|
Invention
|
Rna replicon for reprogramming somatic cells. The present invention embraces a RNA replicon that ... |
|
|
Invention
|
Method of enhancing rna expression in a cell. The present invention describes a virus-derived fac... |
|
|
Invention
|
Antibodies useful in cancer diagnosis. The invention relates to antibodies directed against an ep... |
|
|
Invention
|
Agents for treatment of claudin expressing cancer diseases. The present invention provides bindin... |
|
|
Invention
|
Individualized vaccines for cancer. The present invention is in the field of tumor immunotherapy.... |
|
|
Invention
|
Rna for treatment of autoimmune diseases. The present invention relates to non-immunogenic RNA. T... |
|
|
Invention
|
Methods and compositions for stimulating immune response. The present invention relates to method... |
|
2017
|
Invention
|
Formulation for administration of rna. The present invention relates to compositions comprising p... |
|
|
Invention
|
Methods for characterizing loss of antigen presentation. This invention relates to methods for sc... |
|
|
Invention
|
Rna replicon for versatile and efficient gene expression. The present invention embraces a RNA re... |
|
2015
|
G/S
|
Software. Scientific services. |
|
|
G/S
|
Software. Scientific and technological services. Medical services. |
|
|
G/S
|
Software. Scientific services. Medical services. |
|
|
Invention
|
Methods and kits for the diagnosis of cancer. The present invention relates to methods and kits f... |
